{{Link style|time=2015-12-12T05:12:16+00:00}}
{{protein
| Name = 血管紧张素1型受体，AT<sub>1</sub>受体
| caption = 
| image = 
| width = 
| HGNCid = 336
| Symbol = [[Angiotensin_II_receptor_type_1|AGTR1]]
| AltSymbols = AGTR1B
| EntrezGene = 185
| OMIM = 106165
| RefSeq = NM_000685
| UniProt = P30556
| PDB = 
| ECnumber = 
| Chromosome = 3
| Arm = q
| Band = 21
| LocusSupplementaryData = -q25
}}
{{protein
| Name = 血管紧张素2型受体，AT<sub>2</sub>受体
| caption = 
| image = 
| width = 
| HGNCid = 338
| Symbol = [[Angiotensin_II_receptor_type_2|AGTR2]]
| AltSymbols = 
| EntrezGene = 186
| OMIM = 300034
| RefSeq = NM_000686
| UniProt = P50052
| PDB = 
| ECnumber = 
| Chromosome = X
| Arm = q
| Band = 22
| LocusSupplementaryData = -q23
}}

'''血管紧张素受体'''（{{lang-en|angiotensin receptors}}）是以[[血管紧张素|血管紧张素]]作为[[配体|配体]]的[[G蛋白偶联受体|G蛋白偶联受体]]。<ref name="pmid10977869">{{cite journal | author = de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T | title = International union of pharmacology. XXIII. The angiotensin II receptors | journal = Pharmacol. Rev. | volume = 52 | issue = 3 | pages = 415–72 | year = 2000 | pmid = 10977869 | doi =  | issn =  | url = http://pharmrev.aspetjournals.org/cgi/content/abstract/52/3/415 | access-date = 2008-12-22 | archive-date = 2009-03-16 | archive-url = https://web.archive.org/web/20090316180325/http://pharmrev.aspetjournals.org/cgi/content/abstract/52/3/415 | dead-url = no }}</ref>它是[[肾素-血管紧张素系统|肾素-血管紧张素系统]]的重要组成部分。<ref name="pmid17346243">{{cite journal | author = Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S| title = Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology | journal = Clin. Sci | volume = 112 | issue = 8 | pages = 417–28 | year = 2007 | pmid = 17346243 | doi = 10.1042/CS20060342| issn = }}</ref>

==亚型==

{| class="wikitable"
!Receptor
!Mechanism <ref>{{Cite web |url=http://senselab.med.yale.edu/NeuronDB/receptors2.asp#Neuropeptide%20Y%20receptors, |title=Senselab |access-date=2008-12-22 |archive-url=https://web.archive.org/web/20090228070451/http://senselab.med.yale.edu/NeuronDB/receptors2.asp#Neuropeptide%20Y%20receptors, |archive-date=2009-02-28 |dead-url=yes }}</ref>
|-
!AT<sub>1</sub> || 
*[[Gq_alpha_subunit|G<sub>q/11</sub>]] 
*[[Gi_alpha_subunit|G<sub>i/o</sub>]]
|-
!AT<sub>2</sub> || 
* [[Gi_alpha_subunit_2|G<sub>i2</sub>]] / [[Gi_alpha_subunit_3|<sub>3</sub>]]
|-
!AT<sub>3</sub> || 
|-
!AT<sub>4</sub> || 
|-
|}

血管紧张素受体主要包括1型受体（[[:en:angiotensin_type_1_receptor|angiotensin type 1 receptor]], AT<sub>1</sub> receptor）和2型受体（[[:en:angiotensin_type_2_receptor|angiotensin type 2 receptor]], AT<sub>2</sub> receptor），此外还有3型和4型受体。AT<sub>1</sub>和AT<sub>2</sub>仅有约30%的序列相同，但[[血管紧张素II|血管紧张素II]]作为其主要配体，与二者有相近的亲和力。

===AT<sub>1</sub>受体===

AT<sub>1</sub>受体是被研究最清楚的血管紧张素受体。

====机制====

AT<sub>1</sub>受体被血管紧张素II激活后，通过偶联的[[Gq_alpha_subunit|G<sub>q/11</sub>]]和[[Gi_alpha_subunit|G<sub>i/o</sub>]]激活[[磷脂酶C|磷脂酶C]]（[[:en:phospholipase_C|phospholipase C, PLC]]）并升高胞浆Ca<sup>2+</sup>离子浓度，进而激活一系列细胞反应，如：[[蛋白激酶C|蛋白激酶C]]（[[:en:protein_kinase_C|protein kinase C]]，PKC）。激活的受体亦能抑制[[腺苷酸环化酶|腺苷酸环化酶]]（[[:en:adenylate_cyclase|adenylate cyclase]]）或激活一些[[酪氨酸激酶|酪氨酸激酶]]（[[:en:tyrosine_kinase|tyrosine kinase]]）。<ref name="pmid17346243">{{cite journal | author = Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S| title = Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology | journal = Clin. Sci | volume = 112 | issue = 8 | pages = 417–28 | year = 2007 | pmid = 17346243 | doi = 10.1042/CS20060342| issn = }}</ref>

====作用====

AT<sub>1</sub>受体激活可引起血管收缩，[[醛固酮|醛固酮]]合成和分泌，增加[[抗利尿激素|血管升压素]]分泌，心肌肥厚，外周[[去甲肾上腺素|去甲肾上腺素]]活动度升高，血管平滑肌细胞增生，肾血流减少，抑制[[肾素|肾素]]分泌，[[肾小管|肾小管]][[重吸收|重吸收]]钠增加，调节[[交感神经|交感神经]]活动度、心脏收缩能力、中枢渗透压感受器和[[细胞外基质|细胞外基质]]合成。<ref name="pmid6083400">{{cite journal | author = Catt KJ, Mendelsohn FA, Millan MA, Aguilera G | title = The role of angiotensin II receptors in vascular regulation | journal = J. Cardiovasc. Pharmacol. | volume = 6 Suppl 4 | issue = | pages = S575–86 | year = 1984 | pmid = 6083400 | doi = 10.1097/00005344-198406004-00004| issn = }}</ref>

===AT<sub>2</sub>受体===

AT<sub>2</sub>在胎儿和新生儿体内大量表达。其作用包括：抑制细胞生长、胎儿组织发育，调节细胞外基质、神经元再生、细胞[[分化|分化]]和[[凋亡|凋亡]]。也可能有血管舒张作用。

===AT<sub>3</sub>和AT<sub>4</sub>受体===

对于AT<sub>3</sub>和AT<sub>4</sub>受体，目前还知之甚少。AT<sub>4</sub>受体可以被血管紧张素II的分解产物[[血管紧张素#血管紧张素IV|血管紧张素IV]]激活，可能在中枢神经系统发挥细胞外基质调节作用。

==参见==

[[血管紧张素|血管紧张素]]

[[肾素-血管紧张素系统|肾素-血管紧张素系统]]

==参考文献==
{{Reflist}}

{{G蛋白耦合受体}}
{{神经肽受体}}

[[Category:G蛋白偶联受体|Category:G蛋白偶联受体]]